Table 1.
Baseline data of the no TXA and TXA groups.
| No TXA (24) | TXA (24) | P value | |
|---|---|---|---|
| Age (yr) | 74.2 ± 4.4 | 73.2 ± 4.4 | 0.435 |
| Sex (M : F) | 6 : 18 | 3 : 21 | 0.461 |
| Body mass index | 25.1 ± 3.7 | 25.0 ± 3.4 | 0.896 |
| Antiplatelet drug medication | 8 | 6 | 0.525 |
| American Shoulder and Elbow Surgeon score | 41.3 ± 18.4 | 39.0 ± 18.2 | 0.679 |
| Implant (A : B : C) | 12 : 9 : 3 | 13 : 7 : 4 | 0.805 |
| Cementing of humeral component | 5 | 2 | 0.416 |
| Subscapularis repair | 19 | 21 | 0.701 |
| Operation time (min) | 66.1 ± 8.2 | 62.9 ± 11.9 | 0.282 |
| Preop Hb (mg/L) | 13.0 ± 1.2 | 13.4 ± 1.1 | 0.239 |
| Preop Hct (L/L) | 38.5 ± 3.3 | 40.1 ± 3.6 | 0.110 |
TXA = trenexamic acid; M = male; F = female; Preop = preoperative; Hb = hemoglobin; Hct = hematocrit; Data are presented as means ± standard deviations; Implant A = DJO Reverse Shoulder Prosthesis (DJO, Austin, TX, USA), B = Tornier reverse shoulder prosthesis (Tornier Inc, Stafford, TX, USA), C = Biomet Comprehensive Reverse Total Shoulder Replacement (Biomet Inc, Warsaw, IN, USA).